{"id":"https://openalex.org/W4385856027","doi":"https://doi.org/10.1097/01.hs9.0000976696.98802.fe","title":"PB2498: A PHASE 1 STUDY OF WU-NK-101 IN PATIENTS WITH RELAPSED OR REFRACTORY (R/R) ACUTE MYELOID LEUKEMIA (AML)","display_name":"PB2498: A PHASE 1 STUDY OF WU-NK-101 IN PATIENTS WITH RELAPSED OR REFRACTORY (R/R) ACUTE MYELOID LEUKEMIA (AML)","publication_year":2023,"publication_date":"2023-08-01","ids":{"openalex":"https://openalex.org/W4385856027","doi":"https://doi.org/10.1097/01.hs9.0000976696.98802.fe"},"language":"en","primary_location":{"id":"doi:10.1097/01.hs9.0000976696.98802.fe","doi":"https://doi.org/10.1097/01.hs9.0000976696.98802.fe","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1097/01.hs9.0000976696.98802.fe","pdf_url":null,"source":{"id":"https://openalex.org/S4210211592","display_name":"HemaSphere","issn_l":"2572-9241","issn":["2572-9241"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","norway-1","oarl","poland-20","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310318547","host_organization_name":"Wolters Kluwer","host_organization_lineage":["https://openalex.org/P4310318547"],"host_organization_lineage_names":["Wolters Kluwer"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"HemaSphere","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"http://dx.doi.org/10.1097/01.hs9.0000976696.98802.fe","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5027659475","display_name":"Amanda F. Cashen","orcid":"https://orcid.org/0000-0001-6809-4566","observed_orcids":["https://orcid.org/0000-0001-6809-4566"]},"institutions":[{"id":"https://openalex.org/I204465549","display_name":"Washington University in St. Louis","ror":"https://ror.org/01yc7t268","country_code":"US","type":"education","lineage":["https://openalex.org/I204465549"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Amanda Cashen","raw_affiliation_strings":["Washington University School of Medicine, St. Louis, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Washington University School of Medicine, St. Louis, United States","institution_ids":["https://openalex.org/I204465549"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018403340","display_name":"Ashkan Emadi","orcid":"https://orcid.org/0000-0003-3769-3210","observed_orcids":["https://orcid.org/0000-0003-3769-3210"]},"institutions":[{"id":"https://openalex.org/I126744593","display_name":"University of Maryland, Baltimore","ror":"https://ror.org/04rq5mt64","country_code":"US","type":"education","lineage":["https://openalex.org/I126744593"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ashkan Emadi","raw_affiliation_strings":["University of Maryland Medical School, Baltimore, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Maryland Medical School, Baltimore, United States","institution_ids":["https://openalex.org/I126744593"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081609702","display_name":"Edward Abadir","orcid":"https://orcid.org/0000-0002-4152-5079","observed_orcids":["https://orcid.org/0000-0002-4152-5079"]},"institutions":[{"id":"https://openalex.org/I2799732068","display_name":"Royal Prince Alfred Hospital","ror":"https://ror.org/05gpvde20","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2799732068"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Edward Abadir","raw_affiliation_strings":["Royal Prince Alfred, Camperdown, NSW, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Royal Prince Alfred, Camperdown, NSW, Australia","institution_ids":["https://openalex.org/I2799732068"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048360588","display_name":"Monzr M. Al Malki","orcid":"https://orcid.org/0000-0001-8226-471X","observed_orcids":["https://orcid.org/0000-0001-8226-471X"]},"institutions":[{"id":"https://openalex.org/I1301076528","display_name":"City Of Hope National Medical Center","ror":"https://ror.org/00w6g5w60","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1301076528"]},{"id":"https://openalex.org/I4210110459","display_name":"City of Hope","ror":"https://ror.org/01z1vct10","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1301076528","https://openalex.org/I4210110459"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Monzr Al Malki","raw_affiliation_strings":["City of Hope, Duarte, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"City of Hope, Duarte, United States","institution_ids":["https://openalex.org/I1301076528","https://openalex.org/I4210110459"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109660777","display_name":"Peter T. Tan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2799740997","display_name":"Royal Perth Hospital","ror":"https://ror.org/00zc2xc51","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2799506148","https://openalex.org/I2799740997","https://openalex.org/I2800882159","https://openalex.org/I4388446364","https://openalex.org/I4405257575"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Peter Tan","raw_affiliation_strings":["Royal Perth Hospital, West Perth, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Royal Perth Hospital, West Perth, Australia","institution_ids":["https://openalex.org/I2799740997"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040303721","display_name":"Joshua F. Zeidner","orcid":"https://orcid.org/0000-0002-9014-1514","observed_orcids":["https://orcid.org/0000-0002-9014-1514"]},"institutions":[{"id":"https://openalex.org/I1333535994","display_name":"University of North Carolina Health Care","ror":"https://ror.org/00qz24g20","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1333535994"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joshua Zeidner","raw_affiliation_strings":["University of North Carolina Healthcare, Chapel Hill, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of North Carolina Healthcare, Chapel Hill, United States","institution_ids":["https://openalex.org/I1333535994"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043226131","display_name":"Natasha Catherine Edwin","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Natasha Edwin","raw_affiliation_strings":["Providence, Portland, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Providence, Portland, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044936210","display_name":"Peter H. Sayre","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]},{"id":"https://openalex.org/I4210110664","display_name":"University of California San Francisco Medical Center","ror":"https://ror.org/01t8svj65","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210110664"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Peter Sayre","raw_affiliation_strings":["University of California San Francisco Health, San Francisco, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California San Francisco Health, San Francisco, United States","institution_ids":["https://openalex.org/I180670191","https://openalex.org/I4210110664"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003368910","display_name":"Lori S. Muffly","orcid":"https://orcid.org/0000-0002-9887-6136","observed_orcids":["https://orcid.org/0000-0002-9887-6136"]},"institutions":[{"id":"https://openalex.org/I4210137306","display_name":"Stanford Medicine","ror":"https://ror.org/03mtd9a03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210137306","https://openalex.org/I97018004"]},{"id":"https://openalex.org/I97018004","display_name":"Stanford University","ror":"https://ror.org/00f54p054","country_code":"US","type":"education","lineage":["https://openalex.org/I97018004"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lori Muffly","raw_affiliation_strings":["Stanford Medicine, Palo Alto, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Stanford Medicine, Palo Alto, United States","institution_ids":["https://openalex.org/I4210137306","https://openalex.org/I97018004"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071994294","display_name":"JOHN B. MUTH","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"John Muth","raw_affiliation_strings":["Wugen, St. Louis, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Wugen, St. Louis, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111833621","display_name":"Kenneth Jacobs","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kenneth Jacobs","raw_affiliation_strings":["Wugen, St. Louis, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Wugen, St. Louis, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090055104","display_name":"Ouiam Bakkacha","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ouiam Bakkacha","raw_affiliation_strings":["Wugen, St. Louis, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Wugen, St. Louis, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022252504","display_name":"Eileen McNulty","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Eileen Mcnulty","raw_affiliation_strings":["Wugen, St. Louis, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Wugen, St. Louis, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005821665","display_name":"Angela Pannunzio","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Angela Pannunzio","raw_affiliation_strings":["Wugen, St. Louis, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Wugen, St. Louis, United States","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5005194853","display_name":"Jan Kenneth Davidson-Moncada","orcid":"https://orcid.org/0000-0001-5550-8088","observed_orcids":["https://orcid.org/0000-0001-5550-8088"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jan Davidson-Moncada","raw_affiliation_strings":["Wugen, St. Louis, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Wugen, St. Louis, United States","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":11,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2480,"currency":"USD","value_usd":2480},"apc_paid":{"value":2480,"currency":"USD","value_usd":2480},"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"7","issue":"S3","first_page":"e98802fe","last_page":"e98802fe"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11020","display_name":"Immune Cell Function and Interaction","score":0.8295999765396118,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11020","display_name":"Immune Cell Function and Interaction","score":0.8295999765396118,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.14010000228881836,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.00419999985024333,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/natural-killer-cells","display_name":"natural killer cells","score":0.6869999766349792},{"id":"https://openalex.org/keywords/relapsed-refractory-acute-myeloid-leukemia","display_name":"relapsed/refractory acute myeloid leukemia","score":0.8859999775886536},{"id":"https://openalex.org/keywords/nk-cell-therapy","display_name":"NK cell therapy","score":0.7139999866485596},{"id":"https://openalex.org/keywords/dose-escalation","display_name":"dose escalation","score":0.7670000195503235},{"id":"https://openalex.org/keywords/safety-and-tolerability","display_name":"safety and tolerability","score":0.9089999794960022},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.8619999885559082},{"id":"https://openalex.org/keywords/pharmacodynamics","display_name":"pharmacodynamics","score":0.8880000114440918},{"id":"https://openalex.org/keywords/immunogenicity","display_name":"immunogenicity","score":0.8920000195503235},{"id":"https://openalex.org/keywords/antileukemic-activity","display_name":"antileukemic activity","score":0.8169999718666077},{"id":"https://openalex.org/keywords/nk-cell-persistence","display_name":"NK cell persistence","score":0.4880000054836273},{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.5529999732971191}],"concepts":[{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.4958218038082123},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.4683857262134552},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.448625385761261},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4310761094093323},{"id":"https://openalex.org/C2780868878","wikidata":"https://www.wikidata.org/wiki/Q1660197","display_name":"Immunogenicity","level":3,"score":0.41522693634033203},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3225007653236389},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.2871585488319397}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1097/01.hs9.0000976696.98802.fe","doi":"https://doi.org/10.1097/01.hs9.0000976696.98802.fe","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1097/01.hs9.0000976696.98802.fe","pdf_url":null,"source":{"id":"https://openalex.org/S4210211592","display_name":"HemaSphere","issn_l":"2572-9241","issn":["2572-9241"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","norway-1","oarl","poland-20","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310318547","host_organization_name":"Wolters Kluwer","host_organization_lineage":["https://openalex.org/P4310318547"],"host_organization_lineage_names":["Wolters Kluwer"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"HemaSphere","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:10429044","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/10429044","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC10429044/pdf/hs9-7-e98802fe.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hemasphere","raw_type":"Text"},{"id":"pmh:oai:doaj.org/article:46c7c81f47e14d98be312ef6f8cd9866","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/46c7c81f47e14d98be312ef6f8cd9866","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"HemaSphere, Vol 7, p e98802fe (2023)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1097/01.hs9.0000976696.98802.fe","doi":"https://doi.org/10.1097/01.hs9.0000976696.98802.fe","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1097/01.hs9.0000976696.98802.fe","pdf_url":null,"source":{"id":"https://openalex.org/S4210211592","display_name":"HemaSphere","issn_l":"2572-9241","issn":["2572-9241"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","norway-1","oarl","poland-20","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310318547","host_organization_name":"Wolters Kluwer","host_organization_lineage":["https://openalex.org/P4310318547"],"host_organization_lineage_names":["Wolters Kluwer"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"HemaSphere","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9907000064849854,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4385856027.pdf","grobid_xml":"https://content.openalex.org/works/W4385856027.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4310107641","https://openalex.org/W4283324314","https://openalex.org/W4310105270","https://openalex.org/W4389229680","https://openalex.org/W4385702958","https://openalex.org/W4400491745","https://openalex.org/W4389230685","https://openalex.org/W4405044325","https://openalex.org/W4308398770","https://openalex.org/W4405039566"],"abstract_inverted_index":{"Topic:":[0],"25.":[1],"Gene":[2],"therapy,":[3,539],"cellular":[4,32],"immunotherapy":[5],"and":[6,56,82,104,112,122,175,188,230,303,324,347,421,487,506,509,524,529],"vaccination":[7],"-":[8],"Clinical":[9,536],"Background:":[10],"Natural":[11],"Killer":[12],"(NK)":[13],"cells":[14,27,40],"are":[15,414,438,449,461],"central":[16,410],"to":[17,23,117,155,181,204,212,245,276,310,313,367,392,432],"anti-tumor":[18,48,152],"immunity,":[19],"with":[20,73,94,218,236,408,435],"the":[21,85,199,259,272,279,286,342,357],"capacity":[22],"directly":[24],"kill":[25],"tumor":[26,109,124],"by":[28,454,502],"recognizing":[29],"markers":[30],"of":[31,87,134,192,243,291,338,345,356,390,402,479,522],"stress":[33],"or":[34,379,404,456,464,467,476,482],"abnormality.":[35],"Through":[36,126],"cytokine":[37],"reprogramming,":[38],"NK":[39,59,75,96,540],"can":[41],"gain":[42],"memory-like":[43],"features":[44,71],"that":[45],"augment":[46,151],"their":[47],"potential.":[49],"WU-NK-101":[50,68,99,130,193,316,346],"is":[51,168,263,424,445],"a":[52,138,160,169,252,296,327,336,388,399],"non-engineered,":[53],"cytokine-reprogrammed,":[54],"expanded,":[55],"cryopreserved":[57],"off-the-shelf":[58],"cell":[60,97],"product":[61,141],"derived":[62],"from":[63,137],"peripheral":[64],"blood":[65],"mononuclear":[66],"cells.":[67],"demonstrates":[69,100],"many":[70],"synonymous":[72],"memory":[74],"cells,":[76,110],"such":[77],"as":[78,282,284],"enhanced":[79,111,156],"activity,":[80],"proliferation,":[81],"persistence":[83],"without":[84,159],"requirement":[86],"additional":[88,266],"engineering":[89],"strategies,":[90],"overcoming":[91],"limitations":[92],"associated":[93],"conventional":[95],"therapies.":[98],"potent":[101],"in":[102,105,163,194,210,271,326,370],"vitro":[103],"vivo":[106],"cytotoxicity":[107],"against":[108],"adaptive":[113],"metabolic":[114],"fitness":[115],"contributing":[116],"resilience":[118],"within":[119],"an":[120],"adverse":[121],"immunosuppressive":[123],"microenviroment.":[125],"large-scale":[127],"feeder-cell-free":[128],"expansion,":[129,375],"enables":[131],"multi-dose":[132],"treatment":[133],"several":[135],"patients":[136,206,247,267,331,376,396],"single":[139],"apheresis":[140],"(Mathyer":[142],"M":[143],"et":[144],"al.":[145],"SITC":[146],"2021).":[147],"Multi-dosing":[148],"may":[149,382],"further":[150,277],"activity":[153,191],"leading":[154],"patient":[157,164],"benefit":[158],"substantial":[161],"increase":[162],"risk.":[165],"Aims:":[166],"This":[167],"Phase":[170,288],"1,":[171,224,322],"open-label,":[172],"dose":[173,200,214,262,290,371],"escalation,":[174],"cohort":[176,273,374],"expansion":[177,274],"study":[178],"(NCT05470140)":[179],"designed":[180],"characterize":[182,278],"safety,":[183,280],"tolerability,":[184,281],"pharmacokinetics,":[185],"pharmacodynamics,":[186],"immunogenicity,":[187],"preliminary":[189],"anti-leukemic":[190],"R/R":[195],"AML.":[196,406],"Methods:":[197],"In":[198,373],"escalation":[201],"phase,":[202],"up":[203,211,391],"18":[205],"will":[207,248,268,294,317,332,348,364,494,511,532],"be":[208,249,269,318,333,365,512,533],"treated":[209,420],"3":[213,244,254,256,339,530],"levels":[215],"(DL),":[216],"starting":[217,306],"300":[219],"x":[220,226,232],"106":[221,227,233],"for":[222,228,234,335,387,426],"DL":[223],"900":[225],"DL2":[229],"1800":[231],"DL3,":[235],"1":[237,368,528],"potential":[238],"de-escalation":[239],"DL.":[240],"Successive":[241],"cohorts":[242],"6":[246,265],"enrolled":[250,270],"using":[251],"standard":[253],"+":[255],"design.":[257],"Once":[258],"maximum":[260],"tolerated/administered":[261],"defined,":[264],"phase":[275],"well":[283],"determine":[285],"recommended":[287],"2":[289,429],"WU-NK-101.":[292,315],"Patients":[293,407,434],"receive":[295,349,383],"lymphodepleting":[297],"chemotherapy":[298],"regimen":[299],"(cyclophosphamide":[300],"50":[301],"mg/kg":[302],"fludarabine":[304],"125mg/kg)":[305],"on":[307,320,497],"days":[308,340],"-6":[309],"-2":[311],"prior":[312,431],"receiving":[314],"administered":[319],"Days":[321],"8,":[323],"15":[325],"28-day":[328],"cycle.":[329],"All":[330],"hospitalized":[334],"minimum":[337],"following":[341],"first":[343],"infusion":[344],"recombinant":[350],"human":[351],"interleukin-2":[352],"every":[353],"other":[354],"day":[355],"cycle":[358,369],"(1":[359],"million":[360],"IU/m2":[361],"qod).":[362],"Treatment":[363],"limited":[366],"escalation.":[372],"achieving":[377],"partial":[378],"complete":[380],"remission":[381],"re-induction":[384],"and/or":[385],"consolidation,":[386],"total":[389],"4":[393],"cycles.":[394],"Eligible":[395],"must":[397],"have":[398,418],"confirmed":[400],"diagnosis":[401],"primary":[403],"secondary":[405],"known":[409],"nervous":[411],"system":[412,485],"involvement":[413],"eligible":[415],"if":[416,440],"they":[417],"been":[419],"cerebrospinal":[422],"fluid":[423],"clear":[425],"at":[427,527],"least":[428],"weeks":[430],"enrollment.":[433],"extramedullary":[436],"disease":[437],"permitted":[439],"bone":[441,503],"marrow":[442,504],"blast":[443,451],"count":[444,452],">5%.":[446],"Key":[447],"exclusions":[448],"circulating":[450],">30,000/\u00b5L":[453],"morphology":[455],"flow":[457],"cytometry":[458],"(cytoreductive":[459],"therapies":[460],"allowed);":[462],"uncontrolled":[463,470,473],"untreated":[465],"bacterial":[466],"viral":[468],"infections;":[469],"angina,":[471],"severe":[472,488],"ventricular":[474],"arrhythmias,":[475],"ECG":[477],"suggestive":[478],"acute":[480],"ischemia":[481],"active":[483],"conduction":[484],"abnormalities;":[486],"renal":[489],"impairment.":[490],"Results:Summary/Conclusion:":[491],"Response":[492,519],"assessment":[493],"take":[495],"place":[496],"Day":[498],"28":[499],"(+/-3":[500],"days),":[501],"aspirate":[505],"core":[507],"biopsy,":[508],"response":[510],"defined":[513],"per":[514],"2022":[515],"European":[516],"LeukemiaNet":[517],"criteria.":[518],"rate,":[520],"duration":[521],"response,":[523],"mortality":[525],"rate":[526],"months":[531],"evaluated.":[534],"Keywords:":[535],"trial,":[537],"Cellular":[538],"cell,":[541],"Acute":[542],"myeloid":[543],"leukemia":[544]},"counts_by_year":[],"updated_date":"2026-11-06T12:05:46.655746","created_date":"2023-08-17T00:00:00"}